Clinical Trials Directory

Trials / Completed

CompletedNCT01937533

Apparent Diffusion Coefficient as a Prognostic Biomarker in Cervical Cancer

Diffusion-weighted MRI at 3T Using an Endovaginal Coil: Evaluating the Prognostic Value of the Apparent Diffusion Coefficient Distribution in Stage 1 Cervical Tumours

Status
Completed
Phase
Study type
Observational
Enrollment
236 (actual)
Sponsor
Institute of Cancer Research, United Kingdom · Academic / Other
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study aims to develop the technique of Diffusion-Weighted Magnetic Resonance Imaging(DW-MRI)for the assessment of stage 1 cervical cancers. An endovaginal receiver coil has been designed and developed at the Institute of Cancer Research and Royal Marsden NHS Foundation Trust for use at high field strengths(3T). This will be used to evaluate if DW-MRI at 3T can be used to differentiate different histological characteristics within whole tumours and so determine if the technique could be of prognostic value. The study hypothesis is that this technique will be able to differentiate tumours with histological features known to be associated with poor prognosis (tumour type, grade and lymphovascular space invasion).

Conditions

Interventions

TypeNameDescription
PROCEDUREMagnetic Resonance Imaging using an endovaginal receiver coil

Timeline

Start date
2013-10-02
Primary completion
2019-05-01
Completion
2019-05-31
First posted
2013-09-09
Last updated
2020-01-28

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01937533. Inclusion in this directory is not an endorsement.